Download PDF
Endoscopy 2013; 45(04): 289-291
DOI: 10.1055/s-0032-1326295
Endoscopy essentials
© Georg Thieme Verlag KG Stuttgart · New York

Colonoscopy, inflammatory bowel disease

S. Samuel
  National Institute for Health Research Biomedical Research Unit, Nottingham Digestive Diseases Centre, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
K. Ragunath
  National Institute for Health Research Biomedical Research Unit, Nottingham Digestive Diseases Centre, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
06 March 2013 (online)

Also available at
    Permissions and Reprints
Endoscopy Essentials

Reviews in the Endoscopy Essentials series cite publications from the past year which, in the authors’ opinion, reflect the state-of-the-art in endoscopy. Alongside a short summary of each paper, authors explain why they consider their selected articles to be of importance.

 

  • References

  • 1 Ignjatovic A, East JE, Subramanian V et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012; 107: 885-890
    CrossrefPubMedSearch in Google Scholar
  • 2 Rutter MD, Saunders BP, Wilkinson KH et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130: 1030-1038
    CrossrefPubMedSearch in Google Scholar
  • 3 Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888
    CrossrefPubMedSearch in Google Scholar
  • 4 Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535
    CrossrefPubMedSearch in Google Scholar
  • 5 Bisschops R, Bessissow T, Baert FJ et al. Chromoendoscopy versus narrow band imaging in ulcerative colitis: a prospective randomized controlled trial. Gastrointest Endosc 2012; 75: AB148
    PubMedSearch in Google Scholar
  • 6 Travis SP, Schnell D, Krzeski P et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-542
    CrossrefPubMedSearch in Google Scholar
  • 7 Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol 2005; 3: 11-24
    CrossrefPubMedSearch in Google Scholar
  • 8 Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141: 1194-1201
    CrossrefPubMedSearch in Google Scholar
  • 9 Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1 (5375) 89-92
    CrossrefPubMedSearch in Google Scholar
  • 10 Sandborn WJ, Regula J, Feagan BG et al. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. Gastroenterology 2009; 137: 1934-1943
    CrossrefPubMedSearch in Google Scholar
  • 11 Samuel S, Bruining DH, Loftus Jr EV et al. Endoscopic skipping of the distal terminal ileum in Crohn’s disease can lead to negative results from ileocolonoscopy. Clin Gastroenterol Hepatol 2012; 10: 1253-1259
    CrossrefPubMedSearch in Google Scholar
  • 12 Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease. AJR Am J Roentgenol 2009; 193: 113-121
    CrossrefPubMedSearch in Google Scholar
  • 13 Behr MA. The path to Crohn’s disease: is mucosal pathology a secondary event?. Inflamm Bowel Dis 2010; 16: 896-902
    CrossrefPubMedSearch in Google Scholar
  • 14 Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn’s disease. Gut 2008; 57: 1-4
    PubMedSearch in Google Scholar
  • 15 D’Haens G, Ferrante M, Vermeire S et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2218-2224
    CrossrefPubMedSearch in Google Scholar
  • 16 Roseth AG, Fagerhol MK, Aadland E et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793-798
    CrossrefPubMedSearch in Google Scholar
  • 17 Schoepfer AM, Beglinger C, Straumann A et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn’s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol 2010; 105: 162-169
    CrossrefPubMedSearch in Google Scholar